Episodic, severe abdominal pain due to isolated jejunal Crohn's disease.
Crohn’s disease
Enteroscopy
Inflammatory bowel disease
Jejunal Crohn’s
Small bowel Crohn’s
Journal
Clinical journal of gastroenterology
ISSN: 1865-7265
Titre abrégé: Clin J Gastroenterol
Pays: Japan
ID NLM: 101477246
Informations de publication
Date de publication:
Aug 2021
Aug 2021
Historique:
received:
18
02
2021
accepted:
16
04
2021
pubmed:
28
4
2021
medline:
27
7
2021
entrez:
27
4
2021
Statut:
ppublish
Résumé
Small bowel Crohn's disease can present with episodic, relapsing, and remitting symptoms and delays in the diagnosis are common. We present a case of a young woman with three years of intermittent abdominal pain and nausea with negative previous evaluations. On presentation, inflammatory markers were elevated, and repeat imaging showed jejunal inflammation, with histopathological examination showing non-caseating granulomas of the small bowel consistent with Crohn's disease. This case highlights the importance of gastroenterologist recognizing the alarm signs in a patient with unexplained symptoms and adds to the literature on the clinical presentation of a rare diagnosis of isolated jejunal Crohn's disease.
Identifiants
pubmed: 33904109
doi: 10.1007/s12328-021-01421-7
pii: 10.1007/s12328-021-01421-7
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1084-1089Informations de copyright
© 2021. Japanese Society of Gastroenterology.
Références
Peery AF, Crockett SD, Murphy CC, et al. Burden and cost of gastrointestinal, liver and pancreatic diseases in the United States: Update 2018. Gastroenterology. 2019;1:254–72.
doi: 10.1053/j.gastro.2018.08.063
Natesan S, Lee J, Volkamer H, Thoureen T. Evidence-based medicine approach to abdominal pain. Emerg Med Clin North Am. 2016;2:165–90.
doi: 10.1016/j.emc.2015.12.008
Rani RA, Raja Ali RA, Lee YY. Irritable bowel syndrome and inflammatory bowel disease overlap syndrome: pieces of the puzzle are falling into place. Intest Res. 2016;4:297–304.
doi: 10.5217/ir.2016.14.4.297
Lacy BE, Pimentel M, Brenner DM, et al. ACG clinical guideline: management of irritable bowel syndrome. Am J Gastroenterol. 2021;1:17–44.
doi: 10.14309/ajg.0000000000001036
Cheifetz AS. Management of active Crohn disease. JAMA. 2013;20:2150–8.
doi: 10.1001/jama.2013.4466
Vavricka SF, Spigaglia SM, Rogler G, et al. Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease. Inflamm Bowel Dis. 2012;3:496–505.
doi: 10.1002/ibd.21719
Torres J, Mehandru S, Colombel JF, Peyrin-Biroulet L. Crohn’s Disease. Lancet. 2017;10090:1741–55.
doi: 10.1016/S0140-6736(16)31711-1
Cottone M, Brignola C, Rosselli M, et al. Relationship between site of disease and familial occurrence in Crohn’s disease. Dig Dis Sci. 1997;42:129–32.
doi: 10.1023/A:1018849524673
Cappello M, Randazzo C, Bravata I, et al. Liver function test abnormalities in patients with inflammatory bowel diseases: a hospital-based survey. Clin Med Insights Gastroenterol. 2014;17:25–31.
Feakins R. Inflammatory bowel disease biopsies: updated British society of gastroenterology reporting guidelines. J Clin Pathol. 2013;12:1005–26.
doi: 10.1136/jclinpath-2013-201885
Yazisiz V. Similarities and differences between Behcet’s disease and Crohn’s disease. World J Gastrointest Pathophysiol. 2014;3:228–38.
doi: 10.4291/wjgp.v5.i3.228
Storch ID, Rosoff L, Katz S. Sarcoidosis and inflammatory bowel disease. J Clin Gastroenterol. 2001;33:345.
doi: 10.1097/00004836-200110000-00023
Ambruster S, Moncur J, Veerappan G. CVID: A masquerader of Crohn’s disease. Inflamm Bowel Dis. 2011;17:s51.
doi: 10.1097/00054725-201112002-00162
Liverani E, Scaioli E, Digby RJ, et al. How to predict clinical relapse in inflammatory bowel disease patients. World J Gastroenterol. 2016;3:1017–33.
doi: 10.3748/wjg.v22.i3.1017
Zimmerman EM, Al-Hawary MM. MRI of the small bowel in patients with Crohn’s disease. Curr Opin Gastroenterol. 2011;2:132–8.
doi: 10.1097/MOG.0b013e3283438e5d
Heresbach D, Alexandre JL, Branger B, et al. Frequency and significance of granulomas in a cohort of incident cases of Crohn’s disease. Gut. 2005;2:215–22.
doi: 10.1136/gut.2004.041715